Upfront treatment of high‐risk neuroblastoma with a combination of 131I‐MIBG and Topotecan

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 1545-5009, Iss. 11, 2015-11 ,pp. : 1886-1891

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of high-risk neuroblastoma in children: recent clinic trial results

By Greengard Emily   Hill-Kayser Christine   Bagatell Rochelle  

Clinical Investigation, Vol. 3, Iss. 11, 2013-11 ,pp. : 1071-1081

Future Science

Access to resources Recommend Favorite

Osteochondroma in long‐term survivors of high‐risk neuroblastoma

By  

CANCER, Vol. 121, Iss. 12, 2015-06 ,pp. : 2090-2096

John Wiley & Sons Inc

Access to resources Recommend Favorite

Value of surgical resection in children with high‐risk neuroblastoma

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 9, 2015-09 ,pp. : 1529-1535

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of Cefepime and Ceftazidime in Combination with Amikacin in the Empirical Treatment of High-risk Patients with Febrile Neutropenia: A Prospective, Randomized, Multicenter Study

By Erman Mustafa   Akova Murat   Akan Hamdi   Korten Volkan   Ferhanoğlu Burhan   Köksal Iftihar   Çetinkaya Yeşim   Uzun Ömrüm   Ünal Serhat  

Scandinavian Journal of Infectious Diseases, Vol. 33, Iss. 11, 2001-11 ,pp. : 827-831

Informa Healthcare

Access to resources Recommend Favorite